Northern Trust’s Zymergen Inc. Common Stock ZY Stock Holding History

Northern Trust’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-115,588	Closed	-$322K	–	4771
2022 Q3	$322K	Buy	115,588 +85,348	+282%	+$207K	﹤0.01%	3657
2022 Q2	$37K	Sell	30,240 -540,983	-95%	-$907K	﹤0.01%	4497
2022 Q1	$1.65M	Sell	571,223 -19,004	-3%	-$80.7K	﹤0.01%	3187
2021 Q4	$3.95M	Buy	590,227 +425,549	+258%	+$4.13M	﹤0.01%	2832
2021 Q3	$2.17M	Sell	164,678 -24,556	-13%	-$521K	﹤0.01%	3245
2021 Q2	$7.57M	Buy	+189,234	New	+$7.47M	﹤0.01%	2566

Northern Trust's ZY Position: Q4 2022 in Review

Northern Trust sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 115,588 shares — an estimated $322K sold.

Northern Trust first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $7.57M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Northern Trust reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 115,588 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $322K.
Northern Trust first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Northern Trust's Zymergen Inc. Common Stock position peaked at $7.57M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.